Results 271 to 280 of about 36,198 (299)
Some of the next articles are maybe not open access.

Myocardial Metabolic Reprogramming in HFpEF

Journal of Cardiovascular Translational Research, 2023
Heart failure (HF) caused by structural or functional cardiac abnormalities is a significant cause of morbidity and mortality worldwide. While HF with reduced ejection fraction (HErEF) is well understood, more than half of patients have HF with preserved ejection fraction (HFpEF).
Zihui Zhang   +5 more
openaire   +2 more sources

Sex Differences in HFpEF

Current Treatment Options in Cardiovascular Medicine, 2020
Heart failure with preserved ejection fraction (HFpEF) disproportionately affects women. Though no unifying theory exists to explain this phenomenon, the purpose of this review is to explore the many factors that likely contribute to this female predominance.
Anna C. O’Kelly, Emily S. Lau
openaire   +1 more source

HFpEF treatment: pharmacological therapy

2018
Heart failure with preserved ejection fraction (HFpEF) is a diverse syndrome characterized by signs and symptoms of heart failure with relatively preserved ejection fraction. Despite the established efficacy of numerous classes of drugs and devices in heart failure with reduced ejection fraction, no specific therapy has yet proven to reduce morbidity ...
Maja Cikes, Scott D. Solomon
openaire   +1 more source

Istaroxime in HFpEF

JACC: Heart Failure, 2023
Ryan J. Tedford, Daniel N. Silverman
openaire   +1 more source

HFPEF AND GLYCEMIC VARIABILITY: GHIDD TRIAL

European Heart Journal Supplements
Abstract Background Recently the guidelines of European Association of Preventive Cardiology reported that the prevalence of diabetes mellitus in patients with diastolic heart failure (HFpEF) is around 31%.
openaire   +1 more source

HFpEF Scores

JACC: Heart Failure
Barry Greenberg   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy